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ABSTRACT  
Objective: To identify the risk factors for significant depressive symptoms in people with visual impairment in 
England and Wales to provide information on who is most at risk and to whom support services could be 
targeted in future.  
Design: A cross-sectional study using baseline data from a pragmatic randomised controlled trial. 
Setting and Participants: 990 participants aged 18 or over attending one of fourteen low vision rehabilitation 
primary care optometry based clinics in South Wales or two hospital clinics in London.  
Outcome measure: A score of ≥6 on the Geriatric Depression Scale (GDS-15) was classed as clinically significant 
depressive symptoms.  
Results: In a multivariable logistic regression model, significant depressive symptoms were associated with 
age (adjusted odds ratio (AOR) = 0.82, 95%CI: 0.66 to 0.90, p<0.001), ethnicity (AOR non-white compared to 
white = 1.72, 95%CI: 1.05 to 2.81, P=0.031), total number of eye conditions (AOR for two versus one condition 
= 0.98 , 95%CI: 0.67 to 1.43; three or more versus one condition = 0.34 , 95%CI: 0.15 to 0.75, p = 0.026), self-
reported health (AOR for excellent versus poor= 0.01, 95%CI: 0.00 to 0.12; very good versus poor= 0.06, 95%CI: 
0.03 to 0.13; good versus poor= 0.14, 95%CI: 0.08 to 0.24;  fair versus poor= 0.28, 95%CI: 0.18 to 0.46, p<0.001) 
and self-reported visual functioning (AOR = 1.45, 95%CI: 1.31 to 1.61, p<0.001). 
Conclusion: Younger age, a non-white ethnicity, fewer eye conditions and poorer self-reported health and 
visual function are risk factors for significant depressive symptoms in this population.  
Trial registration: ISRCTN46824140 
KEYWORDS 
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ARTCILE SUMMARY 
Strengths and Limitations of the Study  
 This is the first study of risk factors for depressive symptoms in people seeking help for vision 
impairment in England and Wales. 
 It benefits from a large sample size (n=990) and a high response rate (n=990/1323, 74.8%) 
which increase the generalisability of the findings. 
 It examines factors which can be readily assessed by practitioners in primary care and general 
hospital clinics who come into contact with people with vision impairment, enabling them to 
be alerted to those most at risk and in need of signposting to support services. 
 However, it excludes some more difficult to measure factors, such as vision specific distress, 
coping style and perceived social support, which may also predict depression in this 
population. 
 The study uses a cross-sectional design so conclusions about direction of causality cannot be 
made. 
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BACKGROUND 
Vison impairment impacts on all aspects of life and is associated with reduced functional ability, falls, social 
isolation and reduced quality-of-life.1-3 There is also a growing awareness that it has a negative impact on 
mental health status too. Population based studies provide robust evidence of an association between vision 
impairment and depression. Typically those with a vision impairment are 2 to 3 times more likely to be 
depressed.4 5 In Britain, for example, a large survey of >13,000 older adults found that the prevalence of 
significant depressive symptoms in those with good vision living in the community was about 4.6% while in 
those with a vision impairment (<6/18) it was 13.5%.5 
The prevalence of significant depressive symptoms is also high in those accessing rehabilitation services. 
Results from a study in Australia found that when screened with the two item Patient Health Questionnaire 
(PHQ-2), 37% of patients attending rehabilitation clinics or eye care services screened positive for depressive 
symptoms.6 Here in the UK, we screened over 1000 patients attending low vision rehabilitation appointments 
using the Geriatric Depression Scale (GDS-15), as part of the Depression in Visual Impairment Trial (DEPVIT), a 
randomised controlled trial.7 We found that 43% of patients reported significant depressive symptoms (score 
≥6) and, significantly, 74.8% were not receiving any treatment for depression.8 This finding supports previous 
reports that people with a vision impairment are less likely to have their depression identified than those with 
good vision.9-11 
Because depression goes under-detected in this patient group, there is a need to improve routine screening. 
The National Institute for Health and Care Excellence (NICE), in their guidelines on ‘Depression in adults with 
a chronic physical health problem’12 suggest that practitioners working in primary care and general hospital 
clinics should be aware that patients with a chronic physical health problem, especially those with functional 
impairment, are at a high risk of depression. They recommend being alert to possible depression and asking 
two simple screening questions to detect depression.12 Those screening positively should be referred to an 
appropriate professional for assessment, in most cases, the patient’s General Practitioner (GP). Screening 
should occur in both low vision specific settings such as rehabilitation clinics, and in primary care and general 
clinical settings such as diabetes or stroke clinics, where vision impairment is prevalent. In busy primary care 
and general clinics, understanding who is most at risk of depression amongst this patient group using easy to 
determine factors may help clinicians to target depression screening and signpost patients to supportive 
services.  
Previous cross-sectional studies of patients from outpatient eye clinics and low vision rehabilitation services 
have identified several risk factors for depression including: being female, being relatively younger in age, 
living alone and having lower acceptance of vision loss13, reporting poorer self-reported health and having a 
history of mental health problems,13 14 reporting poorer vision specific functioning, higher levels of vision 
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specific distress, having an avoidant coping style and lower perceived adequacy of social support14. A 
longitudinal prospective cohort study of 540 patients from outpatient low vision organisations in the 
Netherlands and Belgium found that people who developed depressive symptoms over a two year period were 
more likely to be: living alone, having just enough money to cover their expenses, have macular degeneration, 
have problems with adaptation to vision loss, have reduced health related quality of life and be experiencing 
symptoms of anxiety.15 
The above studies were conducted in the Netherlands, Belgium and Australia and we do not know if the same 
risk factors apply to a British population. Therefore, it is useful to examine the risk factors for depressive 
symptoms in people with sight loss in England and Wales, using a large sample of consecutive attendees to 
services. The findings will enable clinicians in primary care and general hospital clinics to allocate resources to 
screening those most at risk. 
The aim of this study was to identify the risk factors for significant depressive symptoms in people with vision 
impairment attending rehabilitation clinics in England and Wales using baseline data from a randomised 
controlled trial of interventions for depression (DEPVIT).7 We focused our examination mainly on 
characteristics which can be easily identified in routine practice for example, age and ethnicity, to provide a 
straightforward approach to identifying high risk patients based on readily available information.  
 
METHODS 
Study Design and Participants 
This cross-sectional study was undertaken as part of the Depression in Visual Impairment Trial (DEPVIT).7 
Eligible participants were consecutive adult patients who were seeking help for vision impairment at specialist 
visual rehabilitation services taking part in DEPVIT. Fourteen primary care based rehabilitation services 
recruited participants in South Wales. Services were readily accessible high street practices, accepted self-
referral and tended to cater to older adults with age-related eye conditions living in the local community. A 
secondary care rehabilitation clinic based at Guys and St Thomas’ Hospital and an NHS outreach clinic 
providing low vision services in Southwark recruited participants from the London area. Access to these two 
specialist clinics was by referral only. All consecutive attendees aged 18 or over were considered eligible for 
the study, unless they lived outside the catchment area for the trial or if they had previously been screened 
for depression as part of the study (some people had more than one appointment during the length of the 
study, but we only wanted to screen them and invite them to take part once). Ethical approval was obtained 
from the NHS South East Wales Research Ethics Committee Panel B. All participants provided written informed 
consent for their anonymised data to be used and the study adhered to the Declaration of Helsinki. 
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Funding and Public and Patient Involvement 
The study was funded by Guide Dogs, a voluntary sector organisation who work closely with people with vision 
impairment and understand their experiences and preferences. They carried out a review prior to funding to 
ensure the research questions were relevant and the study design appropriate. Patients with a vision 
impairment reviewed and provided feedback on the depression questionnaire. Patients were not involved in 
the recruitment to or conduct of the study. 
Measures  
Depression 
The Geriatric Depression Scale (GDS-15)16 is one of the most widely used instruments for the screening of 
depression in older adults. The questionnaire has 15 questions and completion time is approximately 5 
minutes. Possible scores range from 0 to 15, with higher scores indicating a greater number of depressive 
symptoms. We chose to use dichotomous categories rather than the continuous scale as this reflects the 
scale’s use in clinical practice as a screening tool to identify those who warrant further investigation.  We used 
the conventional scoring approach rather than Rasch analysis to facilitate direct comparison with published 
studies and to facilitate clinically valid results. A score of 6 or more was taken to be indicative of significant 
depressive symptoms5.  
Risk Factors 
We recorded gender, age, ethnicity (White, Asian/Asian British, Black/Black British or Other), physical illness 
(number and type from a list of seven plus an ‘other’ category) and ocular diagnosis (number and type of eye 
conditions from a list of five plus an ‘other’ category), factors which would be readily available to clinicians 
working with people with sight loss and have been considered in previous studies. 
We also measured self-reported general health as this has consistently been shown to be a risk factor for 
depression6 13-15 and can be easily measured using a single item question from the SF-12, “In general, would 
you say your overall health is: excellent, very good, good, fair or poor?”. The question has had widespread use 
as a single-item measure, including in previous studies of visual impairment and depression5 14 and has shown 
to be significantly and independently associated with specific health problems, use of health services, changes 
in functional status, recovery from episodes of ill health, mortality, and sociodemographic characteristics of 
respondents.17 
To provide information on vision related factors for low vision practitioners who have access to this 
information, we also measured presenting corrected binocular visual acuity using ETDRS LogMAR and 
recorded time since vision loss in years. As previous studies have found no evidence of an association between 
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objective measures of visual acuity and depression13-15, we were interested to see whether a subjective 
measure of visual function would be associated. Self-reported visual functioning was measured using the 7 
item National Eye Institute Visual Function Questionnaire (NEI-VFQ 7) which includes a subset of questions 
from the National Eye Institute Visual Function Questionnaire that have previously been shown to be 
responsive to rehabilitation service intervention.18 As the NEI-VFQ 7 is commonly reported in the published 
literature with Rasch analysis, we transformed the Likert responses using the Rasch derived scoring key 
provided by Ryan et al (2008)18 to calculate a score for each completed questionnaire. A higher score indicates 
a greater perceived difficulty with visual functioning. Questionnaires with 3 or more missing items were 
counted as missing and excluded from the analysis. 
Procedures  
Participants who were eligible to take part in the study were sent a questionnaire in large print format 
containing the GDS-15, NEI-VFQ 7 and single-item question about health, along with their appointment letter 
at least one week before their low vision assessment. They were asked to complete the questionnaire at home, 
with assistance if needed, and to bring it along to their appointment. Those who did not return a completed 
questionnaire were given the opportunity to complete another copy at the clinic, before their appointment. 
The low vision practitioner reviewed the participant’s responses with them at the start of the assessment and 
asked for their written consent to use their anonymised responses in the study. For those who consented, 
information on gender, date of birth, ethnicity, physical illness,  ocular diagnosis, corrected ETDRS Log MAR 
acuity and time since vision loss first identified were recorded on a Case Report Form (CRF). Those who 
screened positive for depressive symptoms (GDS-15 score of ≥6) were offered entry to the DEPVIT trial if 
eligible, or a referral to their GP if not eligible.19 
Case Report Forms completed by the clinicians were sent to the research coordinating centre at Cardiff 
University by secure FAX where the validity and completeness of the data was checked. Any missing or out of 
range data were queried with the practitioner and checked with clinical notes. Five percent of all CRFs and 
surveys were double entered. The error rate was less than 2% and identified errors were corrected. The 
number of eligible patients who did not complete the survey and the number who did not consent for their 
data to be used for research purposes were also recorded. The final dataset was then locked and transferred 
to the statistical team for analysis. The descriptive statistics were tabulated using SPSS Version 23 and the 
regression models were fitted using STATA Version 13.1.   
Statistical analysis  
Participant characteristics were summarised for those with significant depressive symptoms (GDS-15 ≥6) and 
those without (GDS-15 <6). Categorical variables were summarised as numbers and percentages and 
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continuous variables as medians with interquartile ranges.  In all cases we report the number of participants 
for whom data was missing.  
Where the GDS-15 was not fully completed, completed answers were totalled to give a final score provided 
that the number of questions not answered was 2 or less5. If 3 or more questions were unanswered, the GDS-
15 data were regarded as missing and the participant excluded from the analysis.   
Logistic regression was used to determine the independent relationship between each of the potential risk 
factors and significant depressive symptoms. The potential risk factors were initially included individually 
(univariable analysis) and then entered into a multivariable logistic regression analyses in blocks to determine 
which variables remain associated with significant depressive symptoms after controlling for the other factors. 
The events-per-variable was sufficient to allow inclusion of all potential risk factors, so no selection was 
required.20 However, due to co-linearity, it was not possible to include both number and type of physical 
illnesses or both number and type of eye conditions. Therefore, a decision was made to include only number 
of illnesses and eye conditions, as it was hypothesized that burden of multiple diagnoses would be more 
important than type of diagnosis:  those with multiple morbidity are at twice the risk of depression than those 
without multiple morbidity.21 The variables were entered into the analysis in blocks, starting with the risk 
factors which could be most easily identified in routine clinics, and ending with those requiring more time or 
adaptation to practice to assess. The blocks were: 1) Demographics (gender/age/ethnicity), 2) Demographics 
and Physical Health (number of illnesses), 3) Demographics, Physical health and Eye health (number of eye 
conditions/visual acuity/time since vision loss), 4) Demographics, Physical Health, Eye health and Self-report 
measures (self-report health/visual functioning). We calculated the area under the ROC curve to quantify the 
overall ability of each (additional) block of variables to correctly discriminate between those with and without 
depression. 
 
RESULTS 
A total of 1323 consecutive adult patients attended the low vision rehabilitation clinics during the 30 month 
recruitment period. Of these, 312 were not screened for depression because the practitioner felt it was 
inappropriate at the time (because the patient was too ill, had dementia or was recently bereaved); or the 
patient had forgotten to complete the questionnaire and there was no time at the assessment; or they did not 
consent for their data to be used for research.  An additional 21 patients had 3 or more missing items on the 
GDS-15 and were excluded, leaving a final sample size of 990 and a complete response rate of 74.8%. The 
median age of the participants was 79.0 years (IQR= 66.0 to 85.0), 62.2% were female (n=616) and 85% were 
white (n= 842). The overall prevalence of significant depressive symptoms was 42.5%. This varies very slightly 
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from our previously reported study (43%)8 due to the methodology used in this study to calculate the total 
GDS-15 score (excluding those with ≥3 missing items). 
 
Tables 1-4. outline the demographic characteristics of the participants, their physical health measures, eye 
health measures and self-report health and vision measures respectively, split by those with and without 
significant depressive symptoms. They also summarise the results of the univariable logistic regression using 
odds ratios (OR) presented with 95% confidence intervals (CI) and P values. The variables ethnicity, number of 
physical illnesses and number of eye conditions had a small number of participants in some categories, hence 
the categories were collapsed before being entered into the regression analysis. Both the original and 
collapsed categories are presented in the tables. Table 5 Summarises the results of the multivariable logistic 
regression using adjusted odds ratios (AOR) and are presented with 95% confidence intervals (CI) and P values. 
 
 Table 1. Summarises the demographic characteristics of those with and without significant depressive 
symptoms 
 
^Reference category   ~Collapsed categories entered instead  
Demographic 
Characteristics 
 
GDS-15  
Score <6 
GDS-15  
Score ≥6 
Total Univariable logistic regression analysis 
Total Sample, n (%) 
 
569 (57.5%) 421 (42.5%) 990 N OR 95% CI P Value 
Gender, n (%) 
   Male^ 
   Female 
   Data missing 
 
 
201 (53.7%) 
368 (59.7%) 
0 
 
173 (46.3%) 
248 (40.3%) 
0 
 
374 
616 
0  
 
 
990 
 
 
0.78 
 
 
0.60 to 1.01 
 
 
0.064 
Age (years), Median (IQR) 
 
 
Data missing, n (%) 
 
80.0 (72.0, 86.0) 
 
 
22 (52.4%) 
77.0 (57.0, 85.0) 
 
 
20 (47.6%) 
79.0 
(66.0, 
85.0) 
42  
 
948 
 
0.82 
 
0.74 to 0.90 
 
<0.001 
Ethnicity, n (%) 
   White 
   Asian/Asian/British 
   Black/Black British 
   Other ethnic group 
   Data missing 
 
 
508 (60.3%) 
12 (52.2%) 
40 (38.5%) 
9 (45%) 
0 (0%) 
 
334 (39.7%) 
11 (47.8%) 
64 (61.5%) 
11 (55%) 
1 (100%) 
 
842 
23  
104 
20  
1  
 
 
 
Not entered into regression analysis~ 
Ethnicity (collapsed), n(%) 
    White^ 
    Non-White 
    Data missing 
 
 
508 (60.3%) 
61 (41.5%) 
0 (0%) 
 
334 (39.7%) 
86 (58.5%) 
1 (100%) 
 
842 
147 
1 
 
 
989 
 
 
2.14 
 
 
1.50 to 3.06 
 
 
<0.001 
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Table 2. Summarises the physical health of those with and without significant depressive symptoms 
Physical health  
 
GDS-15 
Score <6 
GDS-15 
Score ≥6 
Total Univariable logistic regression 
analysis 
 N OR 95% CI P Value 
Physical Illnesses*, n (%) 
  Diabetes  
  Epilepsy  
  Stroke 
  Thyroid 
  Heart Disease 
  High Blood Pressure 
  Respiratory Disease 
  Other 
  No medical illness 
  Data missing  
  
 
119 (47.8%) 
8 (57.1%) 
31 (50.8%) 
27 (47.4%) 
94 (50.3%) 
246 (55.5%) 
48 (59.3%) 
113 (48.9%) 
113 (70.2%) 
4 (100%) 
 
130 (52.2%) 
6 (42.9%) 
30 (49.2%) 
30 (52.6%) 
93 (49.7%) 
197 (44.5%) 
33 (40.7%) 
118 (51.1%) 
48 (29.8%) 
0 (0%) 
 
249 
14 
61 
57 
187 
443 
81 
231 
161 
4  
 
 
 
 
 
Not entered into regression analysis+ 
Total number of  
physical illnesses, n (%)   
  0 
  1 
  2 
  3 
  4 
  5 
  6 
  Data missing 
 
 
 
113 (70.2%) 
277 (60.6%) 
127 (48.3%) 
41 (47.7%) 
4 (28.6%) 
2 (50%) 
1 (100%) 
4 (100%) 
 
 
48 (29.8%) 
180 (39.4%) 
136 (51.7%) 
45 (52.3%) 
10 (71.4%) 
2 (50%) 
0 (0%) 
0 (0%) 
 
 
161 
457 
263 
86 
14 
4 
1 
4 
 
 
 
 
 
Not entered into regression 
analysis~ 
Total number of physical illnesses 
(collapsed categories), n (%) 
  0^ 
  1   
  2 
  3 or more 
  Data missing 
 
 
113 (70.2%) 
277 (60.6%) 
127 (48.3%) 
48 (45.7%) 
4 (100%) 
 
 
48 (29.8%) 
180 (39.4%) 
136 (51.7%) 
57 (54.3%) 
0 (0%) 
 
 
161 
457 
263 
105 
4  
 
 
 
 
986 
 
 
 
 
1.53 
2.52 
2.80 
 
 
 
1.04 to 2.25 
1.66 to 3.82 
1.68 to 4.66 
 
 
 
 
<0.001 
 
* Participants may have had more than one physical illness +Not entered due to high correlation with number 
of physical illnesses ~Collapsed categories entered instead  ^Reference category   
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Table 3. Summarises the eye health of those with and without significant depressive symptoms 
Eye health  GDS-15 
Score <6 
GDS-15  
Score ≥6 
Total Univariable logistic regression 
analysis 
 N OR 95% CI P Value 
Ocular Diagnosis*, n (%) 
    AMD wet   
    AMD dry  
    Glaucoma  
    Cataract 
    Diabetic eye disease 
    Other eye condition 
    Data missing  
        
 
117 (59.4%) 
259 (64.6%) 
104 (63.0%) 
95 (70.4%) 
59 (48.0%) 
157 (47.9%) 
1 (50%) 
 
80 (40.6%) 
142 (35.4%) 
61 (37%) 
40 (29.6%) 
64 (52.0%) 
171 (52.1%) 
1 (50%) 
 
197 
401 
165 
135 
123 
328 
2 
 
 
 
 
Not entered into regression analysis+ 
Total number  
of eye conditions, n (%) 
   1 
   2 
   3 
   4 
   5 
   Data missing 
  
 
 
381 (56%) 
153 (58.8%) 
32 (72.7%) 
2 (66.7%) 
0 (0%) 
1 (50%) 
 
 
299 (44.0%) 
107 (41.2%) 
12 (27.3%) 
1 (33.3%) 
1 (100%) 
1 (50%) 
 
 
680 
260 
44 
3 
1 
2 
 
 
 
 
Not entered into regression analysis~ 
Total number of eye  
conditions (collapsed), n(%) 
  1^ 
  2 
  3 or more 
  Data missing 
 
 
 
381 (56.0%) 
153 (58.8%) 
34 (70.8%) 
1 (50%) 
 
 
299 (44.0%) 
107 (41.2%) 
14 (29.2%) 
1 (50%) 
 
 
680 
260 
48 
2 
 
 
 
988 
 
 
 
 
0.89 
0.52 
 
 
 
0.67 to 1.19 
0.28 to 1.00 
 
 
 
0.123 
 
Corrected binocular  
visual acuity  (logMar),  
Median (IQR) 
Data missing, n (%) 
0.60 (0.40, 0.94) 
 
 
0  
0.70 (0.50, 1.00) 
 
 
0 
0.67 
(0.40, 1.0) 
 
0 
990 1.01 0.99 to 1.03 0.568 
Years since vision loss,  
Median (IQR) 
 
Data missing, n (%) 
 
5.5 (2.2, 12.0) 
 
 
13 (81.25%) 
5.0 (2.1, 10.2) 
 
 
3 (18.75%) 
5.2  
(2.2, 11.1) 
 
16 
974 0.99 0.99 to 1.01 0.818 
* All ocular diagnoses - participants may have had more than one. +Not entered due to high correlation with 
number of eye conditions ~Collapsed categories entered instead ^Reference category 
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Table 4. Summarises the self-reported health and visual function of those with and without significant 
depressive symptoms 
 
 ^Reference category *NEI VFQ-7 scores have been Rasch analysed and a higher score indicates a greater 
perceived difficulty with visual functioning.  
 
The variables ethnicity, number of physical illnesses and number of eye conditions had a small number of 
participants in some categories, hence the categories were collapsed before being entered into the regression 
analysis. Both the original and collapsed categories are presented in the tables. Table 5 Summarises the results 
of themultivariable logistic regression using odds ratios (OR) and adjusted odds ratios (AOR) and are presented 
with 95% confidence intervals (CI) and p values.  
Self-report measures GDS-15  
Score <6 
GDS-15  
Score ≥6 
Total Univariable logistic regression 
analysis 
 N OR 95%CI P 
Value 
Self-rated health 
(SF-12), n (%) 
   Excellent 
   Very Good 
   Good 
    Fair 
    Poor^ 
    Data Missing 
 
 
22 (95.7%) 
93 (86.1%) 
201 (72.6%) 
192 (52.5%) 
33 (18.5%) 
28 (73.7%) 
 
 
 
 
1 (4.3%) 
15 (13.9%) 
76 (27.4%) 
174 (47.5%) 
145 (81.5%) 
10 (26.3%) 
 
 
23 
108 
277 
366 
178 
38 
 
 
 
 
952 
 
 
 
0.01 
0.04 
0.09 
0.21 
 
 
0.00 to 0.08 
0.02 to 0.07 
0.05 to 0.14 
0.13 to 0.32 
 
 
 
 
 
<0.001 
Visual functioning*  
(NEI VFQ-7), Median (IQR) 
 
Data missing n (%) 
 
0.23 (-1.43, 1.46) 
23 (67.6%) 
1.41 (0.17, 2.49) 
11 (32.4%) 
0.78  
(-0.80, 
1.91) 
34 
956 1.48 1.36 to 1.60 <0.001 
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Block Characteristic Multivariable  
Block 1 
N=947 
Multivariable  
Block 2 
N=943 
Multivariable 
Block 3 
N=926 
Multivariable 
Block 4 
N=877 
AOR 95% CI P AOR 95% CI P AOR 95% CI P AOR 95% CI P 
1. Demographics Gender: Reference category male     
 Female 0.87 0.66 to 
1.14 
0.311 0.89 0.67 to 
1.17 
0.390 0.90 0.68 to 
1.19 
0.462 0.85 0.61 to 
1.19 
0.350 
Age (per decade) 0.82 0.82 to 
0.90 
<0.001 0.82 0.74 to 
0.90 
<0.001 0.82 0.74 to 
0.90 
<0.001 0.82 0.66 to 
0.90 
<0.001 
Ethnicity: Reference category white     
 Non-white 1.54 1.05 to 
2.27 
0.027 1.64 1.10 to 
2.43 
0.014 1.61 1.08 to 
2.40 
0.020 1.72 1.05 to 
2.81 
0.031 
2. Physical Health Total illnesses: Reference category 0 illness     
 1 illness 
 
2.06 1.34 to 
3.18 
 
 
 
<0.001 
2.09 1.36 to 
3.24 
 
 
 
<0.001 
1.28 0.77 to 
2.13 
 
 
 
0.051 
 2 illnesses 3.55 2.23 to 
5.65 
3.62 2.26 to 
5.78 
1.96 1.14 to 
3.37 
 3 + illnesses 3.91 2.24 to 
6.82 
4.02 2.27 to 
7.11 
1.68 0.86 to 
3.29 
3. Eye Health Total eye conditions: Reference category 1 cond.     
 2 conditions 
 
0.91 0.66 to 
1.27 
 
 
0.114 
0.98 0.67 to 
1.43 
 
 
0.026  3 + conditions 0.48 0.24 to 
0.96 
0.34 0.15 to 
0.75 
Visual acuity  1.00 0.98 to 
1.03 
0.929 1.00 0.97 to 
1.03 
0.942 
Time since vision loss (per year) 0.99 0.98 to 
1.00 
0.075 0.99 0.98 to 
1.00 
0.244 
4. Self-report  
Measure 
Subjective Health: Reference category poor    
 
 
 
 
 
 
 
 
 
 Excellent 0.01 0.00 to 
0.12 
 
 
 
 
<0.001 
 Very Good 0.06 0.03 to 
0.13 
 Good 0.14 0.08 to 
0.24 
 Fair 0.28 0.18 to 
0.46 
Visual Functioning 1.45 1.31 to 
1.61 
<0.001 
Area Under ROC Curve 0.59 0.65 0.65 0.81 
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Table 5. Summaries the results of the multivariable regression analyses, with blocks of variables added sequentially to the model. 
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Demographics 
Table 1. Shows that those with a higher prevalence of significant depressive symptoms were male, younger or 
non-white. In the univariable analysis, age and ethnicity were associated with significant depressive 
symptoms. An increase in age was associated with lower odds of participants having depression and having 
ethnicity other than white was associated with higher odds of having depression . These variables remain 
associated once other variables were controlled for in the multivariable analysis final model (Table 5.). There 
was no evidence of an association between gender and significant depressive symptoms.  
 
Physical health 
The prevalence of depression was lowest in those with no physical illness (29.8%) and highest in those with 
three or more illnesses (54.3% - Table 2.). In the univariable analysis, an increase in the number of physical 
illnesses was associated with higher odds of having significant depressive symptoms. This association 
remained when controlling for demographics and eye health but was no longer associated when controlling 
for subjective health and visual function. 
 
Eye health 
Those with a higher prevalence of depression had one eye condition, worse visual acuity or less time since 
vision loss (Table 3.). The univariable analysis found no evidence of an association between significant 
depressive symptoms and number of eye conditions, visual acuity and time since vision loss. However, when 
controlling for other factors in the final model, an increase in the number of eye conditions was associated 
with lower odds of having significant depressive symptoms.  
 
Self-report measures 
The prevalence of depression was highest in those with poor self-rated health (81.5%) and lowest in those 
with excellent health (4.3%). Those with significant depressive symptoms had worse self-rated visual 
functioning (Table 4.). Worse self-rated health and visual functioning were associated with higher odds of 
having significant depressive symptoms in both the univariable analysis and multivariable final model.  
 
The area under the ROC curve was 0.59 when demographics alone were entered into the model, increasing to 
0.65 when physical and eye health variables were considered, and reaching 0.81 when self-report measures 
were added. 
 
 
DISCUSSION   
 16              V7.0 Final 26th November 2018 
 
This study identified the risk factors for significant depressive symptoms in people with vision impairment 
attending vision rehabilitation clinics in England and Wales. We focused mainly on risk factors which can be 
easily identified in primary care and general hospital clinics, so as to provide a pragmatic approach to 
identifying high risk patients. To inform ophthalmic clinicians who may have access to more detailed 
information on eye health, we also included a range of vision related variables. Our findings showed that 
amongst older adults, those of relatively younger age, with an ethnicity other than white, and poorer self-
reported health and visual function had higher odds of having significant depressive symptoms. Number of 
physical illnesses was an independent predictor of depressive symptoms, but there was no evidence of an 
association when controlling for subjective health and vision function. The number of eye conditions was not 
an independent predictor of depressive symptoms, but was related to depression when other variables were 
controlled: less number of eye conditions was associated with higher odds. There was no evidence that 
gender, time since vision loss and visual acuity were associated with depression. 
With regard to demographic factors, our findings demonstrate some support for, and discrepancies with, 
previous studies. In a study with an Australian population14, a univariate analysis provided evidence that 
younger age was associated with depressive symptoms, and in a European and Australian sample (relatively) 
younger age was shown to be associated with subthreshold depression in a multivariable analysis13. Our study 
corroborates these findings in a UK sample. This perhaps reflects the finding in the general population that 
people aged 40–59 years have higher rates of depression than those aged ≥60 years22 and those in middle-age 
have the highest risk23. The reasons for this are not clearly understood, but one theory is that by mid-life, 
individuals have learnt to adapt to their strengths and weaknesses, and in mid-life ‘quell their infeasible 
aspirations’ 23. In those with vision loss, being affected in middle-age rather than old age may add to this sense 
of lost aspirations and could also result in more restriction in life including difficulties in finding and staying in 
work, playing sport etc. Our research found no evidence of an association between gender and depressive 
symptoms. Previous studies examining this association have differed in their findings. An Australian study 
showed no association in a univariate analysis14, whilst a model with a European and Australian sample found 
being female was a predictor of subthreshold depression13. The authors of a study with Dutch and Belgian 
participants reported that their findings on gender were inconclusive15. Differences in findings across the 
studies may indicate this factor is country specific, or may be due to differences in the measures used to assess 
depression. For example, we included people with all levels of depressive symptoms, whereas the 
European/Australian study included only subthreshold depression. It may be that being female is associated 
with subthreshold depression but there is no association when all levels of severity are considered. We found 
that having an ethnicity other than white was a risk factor. Recent studies on vision impairment and depression 
have not measured ethnicity, however an earlier study conducted in New Zealand found that ethnicity was 
not related to depression24. Differences between that study and ours may be due to the different populations, 
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with a wider variation in ethnicities in the UK and London in particular. The New Zealand study only recorded 
‘New Zealand born European’ or ‘other’. Therefore, future studies should include ethnicity as a variable to 
provide further clarification. 
There is more consistency between European and Australasian studies and our UK study in terms of health. 
We demonstrated that those with poorer self-reported health were at much higher risk of depressive 
symptoms. This confirms previous research in vision impaired people which has shown that poorer perceived 
health status13, poorer self-reported health14 and poorer health related quality of life24 are all predictors of 
depression. This is not surprising as patients may include their emotional health in a question about general 
health. Our study also found that a higher number of physical illnesses was an independent risk factor for 
depression. This is in line with findings from the non-vision impaired population. A recent meta-analysis found 
a substantial relationship between multimorbidity (the presence of two or more chronic physical illnesses) and 
depression, reporting that people with multimorbidity are at twice the risk of depression to those without 
multimorbidity, and nearly three times at risk compared to those with no chronic physical condition21. The 
authors suggest the relationship is bi-directional and cite the Activity Restriction Model of Depressed Affect25 
which explains that multimorbidity contributes significantly to depressive symptoms through having to give 
up valued activities due to physical limitations. In our sample, the limitations of conditions such as stroke and 
diabetes may have compounded any mobility and functional issues already caused by sight loss, which can 
make self-care, engaging in hobbies and getting out and about more difficult.  
In terms of vision related factors, it is logical to assume that the chances of having depressive symptoms 
increases as visual acuity decreases. However, in line with other European and Australian studies13-15, the 
results of the regression analysis do not support this hypothesis. What seems to be more important is self-
reported visual function: those with worse self-reported visual function are more at risk of depressive 
symptoms26. Therefore clinicians should take care not to make assumptions about the likelihood of depression 
in only those with the lowest levels of vision as assessed by visual acuity. The relationship is likely to be 
bidirectional, with poorer visual function leading to loss of valued activities and mood, whilst lowered mood 
may influence a person’s perception of their vision function. As with previous studies13 15, time since the vision 
loss was first identified was also not a predictor of depression, indicating that patients may develop symptoms 
at any point on their sight loss journey.  The more surprising finding was that people with three or more eye 
conditions had lower odds of having significant depressive symptoms than those with just one eye condition. 
On consultation with the literature, we suggest this finding may be explained in terms of acceptance: lower 
acceptance of vision loss has shown to be a predictor of subthreshold depression13. In their work with people 
with diabetic eye disease and partial sight loss (some of whom also had glaucoma), Oehler-Giarratana and 
Fitzgerald report that patients described being in a state of “limbo” where they experienced uncertainty, fear 
and hope that vision might improve27. Perhaps surprisingly, they expressed the view that total loss of vision 
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would be a relief, as they could proceed through a healing phase and make plans for their future care. In our 
study, it is possible that those with three or more eye conditions had come to terms with the likelihood of 
further vision loss and reached a point of acceptance, whereas those with one eye condition were in the 
“limbo” phase, with the hope that sight may improve but the fear that it might deteriorate, and therefore not 
reached this point of acceptance thus increasing their risk of depressive symptoms. None of the studies 
referred to in our introduction included number of eye conditions as a risk factor, and we could not find any 
studies which included both number of eye conditions and level of acceptance. Therefore, further research is 
needed to better understand this finding and possible explanation. Our research suggests that not all of the 
factors related to depressive symptoms in people with vision impairment are specific to that particular 
population. As with the general population, age, ethnicity and health are associated with risk of depression 
and this needs to be taken into consideration when understanding the link between vision impairment and 
depression, and when considering suitable interventions.  
This research added to the literature by examining risk factors in a British sample of people with vision 
impairment. The study benefited from a large sample size and a high response rate, enhancing the 
generalisability of the findings. As we included 14 low vision rehabilitation clinics across primary and secondary 
care, we believe the findings are transferrable to both settings in the UK. Our study employed validated 
measures of depressive symptoms and incorporated risk factors which are easy to identify in primary care and 
hospital clinics. Therefore the results can be easily integrated in clinical practice to target screening. 
However, inevitably there were some value judgements in how we chose our criteria for selecting the range 
of potential factors in our study. This means that other parameters which have previously been shown to be 
predictors of depression, for example, vision specific distress, lower perceived adequacy of social support and 
avoidant coping14, were not measured and therefore cannot be included in the risk profile advice to clinicians. 
These parameters can only be assessed using additional questionnaires which would have increased the 
overall response burden in the study and furthermore, it is unlikely that these variables would be measured 
in routine practice and therefore were not within the scope of our study.  
We chose to dichotomise the GDS-15 to reflect how it would be used in practice, as a screening tool for 
identifying patients who would benefit from screening in clinic and potentially signposting to support services. 
However, we acknowledge that this may have led to a reduction in power and loss of information.28A further 
limitation of the study is the use of a cross-sectional design, which means conclusions about direction of 
causality are not possible. Finally, whilst the completion rate of the GDS-15 was high, a number of patients 
were not screened at the discretion of the practitioners, including because they felt the patient was too ill, 
had dementia or had recently been bereaved, or they did not consent for their answers be used for research. 
Therefore there may be a risk of bias as the non-completers may be systematically different from those that 
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completed the questionnaire and consented to their data being used. Similarly, we excluded cases with 
missing data from the multivariable analysis and this simple approach to missing data may have introduced 
some bias. However, as only 113/990 (11%) were excluded, the risk of bias is low  
For the first time, for a population in England and Wales, our study demonstrates that for patients with vision 
impairment, there are several risk factors for depression which can be easily identified by those coming in to 
contact with people with sight loss. We recommend that all clinicians working with people with sight loss are 
alert to these factors. We advise screening higher risk patients using the simple two question screen 
recommended in the NICE guidelines12. If a patient is identified as having likely depression they should be 
managed according to the guidelines, which includes referral to an appropriate professional, for example, the 
GP. Local pathways should be established to manage this referral. However, because the prevalence of 
depressive symptoms is so high in low vision clinics, we recommend that low vision practitioners introduce 
depression screening as part of routine care with all patients. 
Future research could include qualitative work to clarify the pathway from the risk factors identified here to 
the onset of depression, to aid the development of interventions for depression in this population. 
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